Ligand-Based Pharmacophore Modeling Using Novel 3D Pharmacophore Signatures

被引:38
|
作者
Kutlushina, Alina [1 ]
Khakimova, Aigul [1 ]
Madzhidov, Timur [1 ]
Polishchuk, Pavel [2 ,3 ]
机构
[1] Kazan Fed Univ, AM Butlerov Inst Chem, Kremlevskaya Str 18, Kazan 420008, Russia
[2] Palacky Univ, Fac Med & Dent, Inst Mol & Translat Med, Hnevotinska 5, Olomouc 77900, Czech Republic
[3] Univ Hosp Olomouc, Hnevotinska 5, Olomouc 77900, Czech Republic
来源
MOLECULES | 2018年 / 23卷 / 12期
关键词
3D pharmacophore signatures; 3D pharmacophore hash; pharmacophore modeling; ligand-based modeling; IDENTIFICATION; INHIBITORS; DISCOVERY; EFFICIENT; ALIGNMENT;
D O I
10.3390/molecules23123094
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Pharmacophore modeling is a widely used strategy for finding new hit molecules. Since not all protein targets have available 3D structures, ligand-based approaches are still useful. Currently, there are just a few free ligand-based pharmacophore modeling tools, and these have a lot of restrictions, e.g., using a template molecule for alignment. We developed a new approach to 3D pharmacophore representation and matching which does not require pharmacophore alignment. This representation can be used to quickly find identical pharmacophores in a given set. Based on this representation, a 3D pharmacophore ligand-based modeling approach to search for pharmacophores which preferably match active compounds and do not match inactive ones was developed. The approach searches for 3D pharmacophore models starting from 2D structures of available active and inactive compounds. The implemented approach was successfully applied for several retrospective studies. The results were compared to a 2D similarity search, demonstrating some of the advantages of the developed 3D pharmacophore models. Also, the generated 3D pharmacophore models were able to match the 3D poses of known ligands from their protein-ligand complexes, confirming the validity of the models. The developed approach is available as an open-source software tool: http://www.qsar4u.com/pages/pmapper.php and https://github.com/meddwl/psearch.
引用
收藏
页数:14
相关论文
共 50 条
  • [31] Ligand-based pharmacophore modeling and machine learning for the discovery of potent aurora A kinase inhibitory leads of novel chemotypes
    Banat, Rajaa
    Daoud, Safa
    Taha, Mutasem Omar
    MOLECULAR DIVERSITY, 2024, 28 (06) : 4241 - 4257
  • [32] Ligand-based pharmacophore modeling, virtual screening and biological evaluation to identify novel TGR5 agonists
    Zhao, Shizhen
    Li, Xinping
    Peng, Wenjing
    Wang, Le
    Ye, Wenling
    Zhao, Yang
    Yin, Wenbo
    Chen, Wei-Dong
    Li, Weiguo
    Wang, Yan-Dong
    RSC ADVANCES, 2021, 11 (16) : 9403 - 9409
  • [33] Use of ligand-based pharmacophore modeling and docking approach to find novel acetylcholinesterase inhibitors for treating Alzheimer's
    Dhanjal, Jaspreet Kaur
    Sharma, Sudhanshu
    Grover, Abhinav
    Das, Asmita
    BIOMEDICINE & PHARMACOTHERAPY, 2015, 71 : 146 - 152
  • [34] Quinoline-based Schiff bases as possible antidiabetic agents: ligand-based pharmacophore modeling, 3D QSAR, docking, and molecular dynamics simulations study
    Ranade, Shriram D.
    Alegaon, Shankar G.
    Khatib, Nayeem A.
    Gharge, Shankar
    Kavalapure, Rohini S.
    RSC MEDICINAL CHEMISTRY, 2024, 15 (09): : 3162 - 3179
  • [35] Modeling approaches for ligand-based 3D similarity
    Tresadern, Gary
    Bemporad, Daniele
    FUTURE MEDICINAL CHEMISTRY, 2010, 2 (10) : 1547 - 1561
  • [36] Discovery of Potential Inhibitors for SFRP3: Ligand-Based 3D Pharmacophore, Virtual Screening, Molecular Docking, and Dynamics Studies
    Deepthi, S. Infant
    Sangavi, P.
    Priyanka, G.
    Kirubhanand, C.
    Nachammai, K. T.
    Kumar, S. Gowtham
    Langeswaran, K.
    POLYCYCLIC AROMATIC COMPOUNDS, 2024, 44 (10) : 6714 - 6736
  • [37] Discovery of a nanomolar glyoxalase-I inhibitor using integrated ligand-based pharmacophore modeling and molecular docking
    Nizar A. Al-Shar’i
    Enas K. Al-Rousan
    Lara I. Fakhouri
    Qosay A. Al-Balas
    Mohammad A. Hassan
    Medicinal Chemistry Research, 2020, 29 : 356 - 376
  • [38] Discovery of a nanomolar glyoxalase-I inhibitor using integrated ligand-based pharmacophore modeling and molecular docking
    Al-Shar'i, Nizar A.
    Al-Rousan, Enas K.
    Fakhouri, Lara I.
    Al-Balas, Qosay A.
    Hassan, Mohammad A.
    MEDICINAL CHEMISTRY RESEARCH, 2020, 29 (03) : 356 - 376
  • [39] Network analysis and ligand-based pharmacophore modeling for discovery of small molecule against glioblastoma multiforme
    Radhakrishnan, Vishnu Vasanthi
    Benny, Sonu
    Presanna, Aneesh Thankappan
    FUTURE MEDICINAL CHEMISTRY, 2022, 14 (16) : 1203 - 1218
  • [40] Dynamic ligand-based pharmacophore modeling and virtual screening to identify mycobacterial cyclopropane synthase inhibitors
    Choudhury, Chinmayee
    Priyakumar, U. Deva
    Sastry, G. Narahari
    JOURNAL OF CHEMICAL SCIENCES, 2016, 128 (05) : 719 - 732